Abstract

Results of evaluation of the impact of drugs on indicators of clinical laboratory diagnostics as a criterion of safety of therapy are presented. Antiretroviral therapy for HIV infection was chosen as an example. Information from official sources (summary of product characteristics and medicinal product labels) on the potential impact of antiretroviral drugs registered in the Russian Federation on indicators of clinical laboratory diagnostics was analyzed and systematized. Individual INN and antiretroviral regimens recommended by WHO documents and protocols of follow-up and treatment of patients with HIV infection in the Russian Federation with the maximum and minimum potential impact on indicators of clinical laboratory diagnostics were revealed. The research results can be used to develop recommendations for the rational choice, prescription and use of medicines.

Highlights

  • Results of evaluation of the impact of drugs on indicators of clinical laboratory diagnostics as a criterion of safety of therapy are presented

  • Antiretroviral therapy for HIV infection was chosen as an example

  • Information from official sources on the potential impact of antiretroviral drugs registered in the Russian Federation on indicators of clinical laboratory diagnostics was analyzed and systematized

Read more

Summary

Introduction

Results of evaluation of the impact of drugs on indicators of clinical laboratory diagnostics as a criterion of safety of therapy are presented. АЧТВ — активированное частичное тромбопластиновое время; ЛПНП — липопротеины низкой плотности; ЛПВП — липопротеины высокой плотности; АсАТ — аспартатаминотрансфераза; АлАТ — аланинаминорансфераза; КФК — креатининфосфокиназа; ГГТ — гамма-глутамилтрансфераза; ЩФ — щелочная фосфатаза; ЛДГ — лактатдегидрогеназа; ТТГ — тиротропный гормон. Результаты анализа показателей КЛД, потенциально изменяющихся под действием АРВП Результаты анализа влияния классов АРВП на подгруппы показателей КЛД

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.